---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-032108"
form_type: "8-K"
ticker: "FUL"
cik: "0000039368"
company_name: "FULLER H B CO"
filed_at: "2026-10-06T12:01:39+00:00"
generated_at: "2026-10-12T16:34:09.719384+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.72
calibrated_materiality_score: 0.72
confidence: "high"
source: SEC EDGAR
---

# H.B. Fuller launches $950 million notes offering to fund Advanced Medical Solutions acquisition

## Summary
- H.B. Fuller commenced a private offering of $950 million of senior unsecured notes due 2034, exempt from Securities Act registration under Rule 144A/Reg S.
- Proceeds will fund the acquisition of Advanced Medical Solutions Group plc (AMS), repay credit agreement borrowings and redeem FUL's 4.000% notes due February 15, 2027.
- $450 million of the notes must be redeemed at 100% of issue price if the AMS acquisition is not completed by June 25, 2027.
- Pro forma combined net revenue was $3.867 billion and Adjusted EBITDA $713.5 million, with pro forma net total leverage of 4.2x and 3.3x interest coverage.
- FUL entered a Co-operation Agreement with AMS and H.B. Fuller Medical Adhesive Technologies Inc. on June 25, 2026.

## SEC filing metadata
- accession: 0001437749-26-032108
- form_type: 8-K
- ticker: FUL
- cik: 0000039368
- company_name: FULLER H B CO
- filed_at: 2026-10-06T12:01:39+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.72
- calibrated_materiality_score: 0.72
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/39368/000143774926032108/0001437749-26-032108-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/39368/000143774926032108/ful20261005d_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-032108
- JSON: https://secwatch.observer/filing/0001437749-26-032108.json
- Plain text: https://secwatch.observer/filing/0001437749-26-032108.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.